Concepedia

Elitza Naumova

EN

4

Publications

242

Citations

4

H-Index

2002

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

University of Milan

Elitza Naumova is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, tumor biology, and neuro-oncology.

Top concepts

Publications per year

2002–2006

4

Publications

4

Ki-67: a prognostic factor for low-grade glioma?

Barbara J. Fisher, Elitza Naumova, C. Leighton et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 88 citations

, , +7

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.

Angela Garofalo, Elitza Naumova, Luigi Manenti et al. · PubMed · 2003 · 63 citations

The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis

Elitza Naumova, Paolo Ubezio, Angela Garofalo et al. · Clinical Cancer Research · 2006 · 61 citations · Full text

Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy

Luigi Manenti, Elena Riccardi, Sergio Marchini et al. · Molecular Cancer Therapeutics · 2005 · 30 citations · Full text

Rows per page

1–4 of 4